Moreover, this expression may influence specific downstream targets such as Rearranged L-myc fusion (RLF) and Nucleophosmin 1 (NPM1) expression—critical mediators of cancer growth and chemotherapy resistance. The gene discussed is NPM1; the disease is cancer.